Qube Research & Technologies (QRT)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,211
Closed -$3.04M – 4198
2026
Q2
$3.04M Sell
19,211
-171,506
-90% -$23.2M ﹤0.01% 1900
2026
Q1
$24.4M Buy
190,717
+113,217
+146% +$14.1M 0.03% 770
2025
Q4
$9.45M Buy
+77,500
New +$8.89M 0.01% 1381
2025
Q3
– Sell
-22,595
Closed -$1.87M – 4010
2025
Q2
$1.87M Sell
22,595
-88,367
-80% -$7.05M ﹤0.01% 2217
2025
Q1
$9M Buy
+110,962
New +$9.9M 0.01% 1201
2024
Q4
– Sell
-7,337
Closed -$711K – 3866
2024
Q3
$725K Sell
7,337
-4,733
-39% -$465K ﹤0.01% 2145
2024
Q2
$1.12M Sell
12,070
-73,437
-86% -$6.58M ﹤0.01% 1837
2024
Q1
$8.11M Sell
85,507
-19,837
-19% -$1.84M 0.01% 959
2023
Q4
$9.41M Buy
105,344
+19,837
+23% +$1.47M 0.02% 758
2023
Q3
$6.24M Buy
85,507
+82,238
+2,516% +$6.57M 0.02% 838
2023
Q2
$71.6K Sell
3,269
-7,611
-70% -$636K ﹤0.01% 2010
2023
Q1
$829K Buy
+10,880
New +$903K ﹤0.01% 1364
2022
Q4
– Sell
-78,830
Closed -$6.25M – 3060
2022
Q3
$6.25M Buy
+78,830
New +$6.65M 0.04% 548
2022
Q2
– Sell
-78,087
Closed -$7.02M – 3209
2022
Q1
$7.02M Buy
+78,087
New +$7.21M 0.06% 421
2021
Q3
– Sell
-146,755
Closed -$19.9M – 2846
2021
Q2
$19.9M Buy
+146,755
New +$19.3M 0.23% 91
2021
Q1
– Sell
-203,469
Closed -$28.6M – 2475
2020
Q4
$28.6M Buy
+203,469
New +$26.1M 0.41% 37
2020
Q3
– Sell
-1,357
Closed -$152K – 2165
2020
Q2
$152K Sell
1,357
-16,743
-93% -$1.65M ﹤0.01% 1464
2020
Q1
$1.4M Buy
+18,100
New +$1.6M 0.06% 297

Other funds holding XBI

Qube Research & Technologies (QRT)'s XBI Position: Q3 2026 in Review

Qube Research & Technologies (QRT) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 19,211 shares — an estimated $3.04M sold.

Qube Research & Technologies (QRT) first reported a position in XBI in Q1 2020 and held it in 18 quarters. The position peaked at $28.6M in Q4 2020. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Qube Research & Technologies (QRT) reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 19,211 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $3.04M.
  • Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 18 quarters.
  • Qube Research & Technologies (QRT)'s State Street SPDR S&P Biotech ETF position peaked at $28.6M in Q4 2020.
  • 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.